AIDS

Article	Citations
Epicardial fat and liver stiffness by acoustic radiation force impulse elastography in people with HIV-1 infection without liver disease	112
Bone density changes in young women in Uganda using tenofovir-based HIV preexposure prophylaxis and depot medroxyprogesterone acetate contraception	75
Plasma anti-CD4 IgG levels are not associated with poor immune recovery in people with HIV initiating antiretroviral therapy	70
Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France	68
Amebic liver abscess presenting in a nonendemic region after a 12-year latency in a patient with well controlled HIV infection	66
Strategies for managing weight gain associated with antiretroviral therapy: switch or add?	54
The potential impact of new tuberculosis vaccines on the burden of tuberculosis in people with HIV in South Africa	49
Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis	38
Mitochondrial dysfunction in people with HIV receiving contemporary antiretroviral therapy	37
High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy	35
Risk factors and prognostic significance of anemia in children with HIV infection on antiretroviral therapy	34
Safety and efficacy of switching to 4-weekly albuvirtide plus daily dolutegravir in virologically suppressed HIV-1 adults: a 24-week study	33
The need to avert emergent resistance to dolutegravir in children and adolescents with HIV	30
Beyond virologic suppression	29
Kaposi sarcoma: a fresh look	28
HIV viral suppression in children and adolescents 2 years after transition to dolutegravir: a multicentre cohort study	27
Gestational weight gain in persons with HIV in the United States	26
Impacts of intimate partner violence and sexual abuse on antiretroviral adherence among adolescents living with HIV in South Africa	24
Factors associated with insulin resistance in a longitudinal study of Ugandan youth with and without HIV	24
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin	23
Elevated stress-responsive biomarkers are associated with HIV acquisition in young women in rural South Africa	23
The combined effects of age and HIV on the anatomic distribution of cortical and cancellous bone in the femoral neck among men and women	23
Extracellular vesicle small noncoding RNAs: a window into pathogenesis and diagnosis	22
Country of birth is associated with discrepancies in the prescription of two-drug regimens in successfully treated people with HIV in France	22
Perinatally acquired HIV infection is associated with abnormal blood mitochondrial function during childhood/adolescence	22

Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection	21
Differential genome-wide associated variants and enriched pathways of electrocardiogram parameters among people with versus without HIV	21
Long-acting cabotegravir and rilpivirine for HIV-1 suppression: switch to 2-monthly dosing after 5 years of daily oral therapy	20
Individual and household factors associated with non-disclosure of positive HIV status in a population-based HIV serosurvey	20
Toward demystifying HIV as a risk factor for coronavirus disease 2019 complications	20
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure – two nationwide, population-based cohort studies	20
Association between inflammatory biomarker profiles and cardiovascular risk in individuals with and without HIV	20
The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among MSM in India	20
Impact of preexisting nucleos(t)ide reverse transcriptase inhibitor resistance on the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in treatment experience patients	19
Challenging management of a post-coronavirus disease 2019 invasive Aspergillus sinusitis in a person living with HIV	19
Gut microbiota and plasma metabolites associated with bone mineral density in women with or at risk of HIV infection	19
Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatus	19
Vertical anti-SARS-CoV-2 monoclonal antibody transfer from mothers to HIV-exposed and unexposed infants	18
Triple trouble: syphilitic neuroretinitis preceding progressive outer retinal necrosis in a HIV-infected man	18
Good2Go: perceptions and impact of a community-based comprehensive sexual health screening program in San Diego, California	18
Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens	18
Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapy	17
Evaluating the Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe programme, what's worked and what more needs to be done?	17
A case of primary central nervous system lymphoma in advanced naive HIV-infected patient: the role of antiviral agents	17
Impact of short message service and peer navigation on linkage to care and antiretroviral therapy initiation in South Africa	17
Sex differences in cytokine profiles during suppressive antiretroviral therapy	17
Marked clinical and radiological improvement following pembrolizumab therapy for HIV-associated PML-IRIS	17
Human herpes virus 8-related illness: still with us	16
Longitudinal characterization of circulating extracellular vesicles and small RNA during simian immunodeficiency virus infection and antiretroviral therapy	16
Subclinical cardiac disease in children with perinatally acquired HIV is associated with inflammation	16
Patterns of objectively measured physical activity differ between men living with and without HIV	16
A randomized study of intensified antiretroviral treatment monitoring versus standard-of-care for prevention of drug resistance and antiretroviral treatment switch	16
From policy to practice: uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President's Emergency Plan for AIDS Relief-supported countries, 2017–2020	16
Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIV	15
Sexual behaviours and risk with women in MSM in sub-Saharan Africa	15
Response to comments by Taramasso and colleagues on weight gain stopping/switch rules for antiretroviral clinical trials	15
How the COVID-19 pandemic and the health system's response reduced HIV testing and increased late diagnoses in Mexico	15
Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery	15
Trends in preexposure prophylaxis use among sex partners as reported by persons with HIV – United States, May 2015–June 2020	15
The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuum	15
Mediation analysis of chronic kidney disease risk factors using kidney biomarkers in women living with HIV	15
Explaining racial and ethnic disparities in antiretroviral therapy adherence and viral suppression among U.S. men who have sex with men	14
What's up with the decline in beans? Are there simple tests to identify people with HIV at risk for chronic kidney disease?	14
Trends in hospitalizations and deaths in HIV-infected patients in Spain over two decades	14
Hepatitis delta in patients hospitalized in Spain (1997–2018)	14
Women are from venus: implications for diversified sex-based preexposure prophylaxis approaches	14
Use of dietary supplements containing polyvalent cations and antacids among people with HIV and its impact on viral suppression	14
Comparison of dolutegravir and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV	14
Social context and tracing household wealth over time in rural Uganda 1994–2018	14
Antiretroviral therapy for HIV and intrahepatic hepatitis C virus replication	14
Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs: authors’ reply	14
Bictegravir/emtricitabine/tenofovir alafenamide plus doravirine in highly treatment-experienced men with multidrug-resistant HIV	13
Impact of sub-optimal HIV viral control on activated T cells	13
Reaching for the ‘first 95’: a cross-country analysis of HIV self-testing in nine countries in sub-Saharan Africa	13
Postural instability in HIV infection: relation to central and peripheral nervous system markers	13

An estimate of excess deaths among people with HIV during the coronavirus disease 2019 pandemic in the United States, 2020	13
Using computer-assisted content analysis to advance anal dysplasia natural history research	13
High rate of long-term clinical events after antiretroviral therapy resumption in HIV-positive patients exposed to antiretroviral therapy interruption	13
Cost of improved test and treat strategies in Indonesia	13
A prospective 18F-fluorodeoxyglucose positron emission tomography/computed tomography study of the neurometabolic effects in cocaine use and HIV infection	13
Legacy effect on neuropsychological function in HIV-infected men on combination antiretroviral therapy	13
Underdetection of pre-existing HIV/AIDS during psychiatric hospitalizations	12
T-cell activation and B-cell interaction signatures in rectal tissues are associated with HIV replication in ex-vivo model of infection	12
Human leukocyte antigen B27 and B57 alleles in HIV-infected long-term nonprogressor children	12
The barrier functions of crude cervical mucus plugs against HIV-1 infection in the context of cell-free and cell-to-cell transmission	12
Key milestones and participant engagement strategies in research with HIV-affected adolescents and young adults from low-to-middle income countries	12
Successful treatment of HIV-associated progressive multifocal leukoencephalopathy with pembrolizumab	12
High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV – but HIV viremia matters?	12
County-level predictors of retention in care status among people living with HIV in South Carolina from 2010 to 2016: a data-driven approach	12
Incidence of lung and human papilloma virus-associated malignancies in HIV-infected patients	12
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV	12
A triple case series of uveitis caused by HIV, syphilis and tuberculosis coinfection	12
Unmet needs for HIV ancillary care services by healthcare coverage and Ryan White HIV/AIDS program assistance	12
Utilizing electronic health record data to understand comorbidity burden among people living with HIV: a machine learning approach	12
Neutralization sensitivity of genital tract HIV-1: shift in selective milieu shapes the population available to transmit	12
Thrombotic thrombocytopenic purpura (TTP) in Human immunodeficiency virus (HIV) infected patients: New twists on an old disease	12
Anal cancer incidence in men with HIV who have sex with men: are black men at higher risk?	12
Viremia controls Env-specific antibody-secreting cell responses in simian immunodeficiency virus infected macaques pre and post-antiretroviral therapy	11
Prevalence of HIV testing among black and white transgender adults, 2016–2019	11
In-utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns	11
Intersectionality-informed analysis of durable viral suppression disparities in people with HIV	11
Exposure to doravirine, lamivudine, tenofovir, and raltegravir in a patient with HIV after a Roux-en-Y gastric bypass	11
Dosing lamivudine or emtricitabine in renal impairment: new data confirm it's time for updated guidance!	11
Multimorbidity networks associated with frailty among middle-aged and older people with HIV	11
Neurologic infections in people with HIV: shifting epidemiological and clinical patterns	11
HIV drug resistance monitoring in the era of dolutegravir and injectable long-acting cabotegravir in resource-limited settings	11
IgG4-related disease masquerading as a fungating groin lesion in a patient with HIV and incomplete immune reconstitution	11
Survival following screening and preemptive antifungal therapy for subclinical cryptococcal disease in advanced HIV infection	11
Growing data for recycling tenofovir and lamivudine with dolutegravir as empiric second-line antiretroviral therapy in resource-limited settings	11
Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient with history of cured hepatitis B virus infection and poor immunological status	11
Using serial cross-sectional surveys to create a retrospective nested cohort to determine HIV incidence from 20 US cities	11
A moving target: impacts of lowering viral load suppression cutpoints on progress towards HIV epidemic control goals	11
HIV-1 gp120 amplifies astrocyte elevated gene-1 activity to compromise the integrity of the outer blood–retinal barrier	10
Intersectional stigmas are associated with lower viral suppression rates and antiretroviral therapy adherence among women living with HIV	10
Is tenofovir disoproxil fumarate associated with weight loss?	10
Brain RNA profiling highlights multiple disease pathways in persons with HAND: uncovering determinants of biotype diversity	10
Is the GLP-1 receptor agonist, semaglutide, a good option for weight loss in persons with HIV?	10
Bringing back condoms	10
AIDS: changes in leadership	10
Progress towards achieving national goals for improved quality of life among cis-gender Black women with HIV	10
T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa	10
Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV	10
HIV viral load monitoring during monkeypox virus infection among people with HIV	10
Optimizing behavioral and pharmacological smoking cessation interventions among people with HIV: comment	10
A note of thanks to our reviewers	10
Outcomes of discordant HIV screening test results at a southern academic medical center	10
Provision of HIV preexposure prophylaxis to female patients seeking family planning services in the United States	10
Long-term persistence of transcriptionally-active “defective” HIV-1 proviruses: Implications for persistent immune activation during antiretroviral therapy	10
Analysis of HIV transmission characteristics and intervention effects in Guangxi based on molecular networks	10
Preexposure prophylaxis availability among health facilities participating in the global International epidemiology Databases to Evaluate AIDS (IeDEA) consortium	10
Quantifying the association of individual-level characteristics with disparities in kidney transplant waitlist addition among people with HIV	10
Incidence, clearance, and factors associated with anal human papilloma virus infection among men with HIV	9
Estimates of HIV testing at visits to United States emergency departments	9
Quantifying missed opportunities for tuberculosis among people with HIV in the US President's Emergency Plan for AIDS Relief	9
Leveraging emergency care to reach key populations for ‘the last mile’ in HIV programming: a waiting opportunity	9
Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV	9
Improving adherence to daily preexposure prophylaxis among MSM in Amsterdam by providing feedback via a mobile application	9
Virtual case management: a differentiated approach to HIV prevention, treatment, and care	9
Lower endoscopy, early-onset, and average-onset colon cancer among Medicaid beneficiaries with and without HIV	9
The effect of a social network-based intervention on adherence to HIV pre-exposure prophylaxis and HIV viral suppression among Kenyan fishermen	9
Life expectancy of people with HIV on antiretroviral therapy in Spain	9
Maternal breastfeeding and education impact infant growth and development more than in-utero HIV/antiretroviral therapy exposure in context of universal antiretroviral therapy	9
A systematic review of qualitative research on recently acquired HIV	9
Maternal HIV infection and antiretroviral exposure during pregnancy in fetuses and newborns: when solving one problem opens up a Pandora's box of new conundrums	9
Weight loss associated with semaglutide treatment among people with HIV	9
Racial, gender, and psychosocial disparities in viral suppression trends among people receiving coordinated HIV care in Los Angeles County	9
False-positive HIV screening tests during the COVID-19 pandemic, a passing trend?	9
The clinical utility of three frailty measures in identifying HIV-associated neurocognitive disorders	9
Differences in HIV clinical outcomes amongst heterosexuals in the United Kingdom by ethnicity	9
Fibrocavitary disease caused by Mycobacterium chimaera in a patient with HIV	9
Ex-vivo rectal tissue infection with HIV-1 to assess time to protection following oral preexposure prophylaxis with tenofovir disoproxil/emtricitabine	9
Atazanavir-induced lithiasis evidenced several years after drug discontinuation	8
Durability of switched therapy after failure of WHO-recommended antiretroviral therapy regimens in a resource-limited setting	8
Lower aids-related hospitalizations in women living with HIV multidrug resistance	8
Mpox infection in people living with HIV	8

The impact of past HIV interventions and diagnosis gaps on new HIV acquisitions, transmissions, and HIV-related deaths in Côte d’Ivoire, Mali, and Senegal	8
Lipidome association with vascular disease and inflammation in HIV+ Ugandan children	8
Trends in HIV testing and HIV stage at diagnosis among people newly diagnosed with HIV	8
Monocyte phenotype and extracellular vesicles in HIV-1, HIV-2, and HIV-1/2 dual infection	8
Mathematical modelling of the influence of serosorting on the population-level HIV transmission impact of pre-exposure prophylaxis	8
Pulse wave velocity in early-treated children living with perinatal HIV infection is similar to uninfected children	8
Preterm birth and severe morbidity in hospitalized neonates who are HIV exposed and uninfected compared with HIV unexposed	8
Dolutegravir-induced neural tube defects in mice are folate responsive: Erratum	8
Differential systemic immune-inflammation index levels in people with and without HIV infection	8
The construction of a novel supplementary diagnostic model for patients with indeterminate HIV infection	8
David Katzenstein and James Hakim—In Memoriam	8
Regional variation in weight change after the transition to dolutegravir in Uganda and South Africa	8
Improvement in CD4 count among people with HIV in New York City, 2007-2021: a serial cross-sectional analysis	8
Natural killer cells during acute HIV-1 infection: clues for HIV-1 prevention and therapy	8
Changing costs of preexposure prophylaxis may undermine efforts to curb HIV infection rates	8
Changes in short-term (in-ICU and in-hospital) mortality following Intensive Care Unit admission in adults Living with HIV: 2000–2019	8
HIV transmission among acutely infected participants of a Dutch cohort study 2015–2021 is not associated with large, clustered outbreaks	8
Cardiovascular health among persons with HIV without existing atherosclerotic cardiovascular disease	8
Incidence of HIV-positive admission and inpatient mortality in Malawi (2012–2019)	8
A randomized trial of ‘fresh start’ text messaging to improve return to care in people with HIV who missed appointments in South Africa	8
Cumulative HIV viral load and lower CD4 cell count are associated with incident venous thromboembolism in people with HIV	8
Elimination of perinatal transmission of hepatitis B: lessons learned from women with HIV-HBV coinfection	8
I would but I cannot, I can but I do not want: unmet needs of people with HIV in the long-acting era	8
Effectiveness of topical cidofovir for treatment of refractory anal high-grade squamous intraepithelial lesion (HSIL)	8
Kidney injury biomarkers during exposure to tenofovir-based preexposure prophylaxis	8
HIV accelerates clonal hematopoiesis and cardiovascular aging	8
Application of machine-learning techniques in classification of HIV medical care status for people living with HIV in South Carolina	8
Advanced HIV disease and engagement in care among patients on antiretroviral therapy in South Africa: results from a multi-state model	8
Systematic review and quantitative and qualitative comparative analysis of interventions to address HIV-related stigma and discrimination	8
Impact of rilpivirine cross-resistance on long-acting cabotegravir-rilpivirine in low and middle-income countries	8
Association of envelope-specific B-cell differentiation and viral selective pressure signatures in HIV-1 CRF01_AE infection	8
The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving tenofovir alafenamide/emtricitabine/dolutegravir, tenofovir disoprox	7
Body weight changes in people with HIV starting dolutegravir versus efavirenz-based regimens in a large cohort in rural Tanzania	7
Outcomes of a policy to prioritize populations with expected healthcare barriers for subsidized preexposure prophylaxis care in Amsterdam, the Netherlands	7
Deconvoluting the contribution of antiretroviral choice in weight gain	7
Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals	7
The effect of an HIV preexposure prophylaxis panel management strategy to increase preexposure prophylaxis prescriptions	7
Incident diabetes in course of antiretroviral therapy	7
Performance of patient-collected dried blood specimens for HIV-1 viral load testing in South Africa	7
Keeping up with Streptococcus pneumoniae in children living with HIV: Erratum	7
Proinflammatory and cardiovascular biomarkers are associated with echocardiographic abnormalities in children with HIV taking antiretroviral therapy	7
Associations between social determinants of health and comorbidity and multimorbidity in people of black ethnicities with HIV	7
A new frontier in HIV care: the predictive power of renal biomarkers on heart health	7
The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy	7
HIV in the Russian Federation: mortality, prevalence, risk factors, and current understanding of sexual transmission	7
Women with HIV: increased need for reproductive health services to improve health outcomes	7
Microfinance, retention in care, and mortality among patients enrolled in HIV care in East Africa	7
Keeping up with Streptococcus pneumoniae in children living with HIV	7
Treatment outcomes amongst older people with HIV infection receiving antiretroviral therapy	7
Causes of death in HIV-infected and HIV-uninfected children aged under-five years in western Kenya	7
HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity	7
Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma	7
The association of exposure to DREAMS on sexually acquiring or transmitting HIV amongst adolescent girls and young women living in rural South Africa	7
Associations between efavirenz concentrations, pharmacogenetics and neurocognitive performance in people living with HIV in Nigeria	7
Different effects of the companion antiretroviral drugs on dolutegravir trough concentrations	7
Synergy between low BMI and hyperglycemia at baseline increases tuberculosis incidence among people living with HIV	7
Dramatic improvement of MRI abnormalities of HIV encephalopathy after suppressive antiretroviral therapy	7
Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV	7
Real world use of dolutegravir two drug regimens	7
Association between substance use disorders and sustained viral suppression: a longitudinal analysis among people with HIV in South Carolina	7
Patients with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for hepatitis C virus	7
Can simplified antiretroviral drug combination therapies resist resistance?	7
Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment	7
Mitigating cognitive impairment in people with HIV by targeting potential impacts of toxoplasmic infection	7
Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy – naive adults with HIV-1 infection	7
A genetic variation in Fucosyltransferase 8 accelerates HIV-1 disease progression indicating a role for N-glycan fucosylation	7
Examining incidence of diabetes in people with HIV: tracking the shift in traditional and HIV-related risk factors	7
Association between tight junction proteins and cognitive performance in untreated persons with HIV	7
Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirine	7
To dose-adjust or not to dose-adjust: lamivudine dose in kidney impairment	6
Identification of hepatitis delta superinfection when investigating transaminitis in HIV/hepatitis B virus co-infection	6
Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1	6
Sexually transmitted infections in people with multidrug-resistant HIV	6
The importance of exercise and physical activity in older adults with HIV	6
Dolutegravir-containing HIV therapy reversibly alters mitochondrial health and morphology in cultured human fibroblasts and peripheral blood mononuclear cells	6
Alterations in glutamate, arginine, and energy metabolism characterize cerebrospinal fluid and plasma metabolome of persons with HIV-associated dementia	6
Impact of efavirenz on hormone-positive breast cancer survival in women living with HIV	6
Predicting occupational outcomes from neuropsychological test performance in older people with HIV	6
Age-associated dementia among older people aging with HIV in the United States: a modeling study	6
Differential survival of Brazilian patients with diffuse large B-cell lymphoma with and without HIV infection	6
Dysbiosis of gut microbiota and metabolites during AIDS: implications for CD4+ T cell reduction and immune activation	6
Ending the HIV epidemic in the United States: lessons from Eswatini	6
Using a machine learning approach to explore predictors of healthcare visits as missed opportunities for HIV diagnosis	6
Psychosocial factors account for a proportion of the difference in cognitive performance between persons with and without HIV	6
Increasing HIV prevalence rate among men who have sex with men: results of a comparison of two national surveys	6
Association of age at antiretroviral therapy initiation with CD4+ : CD8+ ratio recovery among virally suppressed people with HIV	6
Pediatric liquid ‘single tablet regimens’ for HIV—a call to action	6
Interferon-free hepatitis C treatment increases a surrogate of atherosclerotic cardiovascular disease risk in Black veterans living with HIV	6
Comparison of HIV prevalence, incidence, and viral load suppression in Zambia population-based HIV impact assessments from 2016 and 2021	6
Predicting acute kidney injury: do we need biomarkers?	6
Life course history of physical and sexual abuse is associated with cardiovascular disease risk among women living with and without HIV	6
A decision analytics model to optimize investment in interventions targeting the HIV preexposure prophylaxis cascade of care	6
From pregnancy to beyond: renewed emphasis on comprehensive HIV prevention in South Africa	6
The relationship between alcohol consumption and risk of HIV in married men in Sub-Saharan Africa	6
Effect of tuberculosis–HIV co-treatment on clinical and growth outcomes among hospitalized children newly initiating antiretroviral therapy	6